DE2445801C2 - Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose - Google Patents
Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer KetoacidoseInfo
- Publication number
- DE2445801C2 DE2445801C2 DE2445801A DE2445801A DE2445801C2 DE 2445801 C2 DE2445801 C2 DE 2445801C2 DE 2445801 A DE2445801 A DE 2445801A DE 2445801 A DE2445801 A DE 2445801A DE 2445801 C2 DE2445801 C2 DE 2445801C2
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- parenterally
- medicinal product
- orally administrable
- diabetic ketoacidosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP48107613A JPS5058213A (fr) | 1973-09-26 | 1973-09-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2445801A1 DE2445801A1 (de) | 1975-04-03 |
DE2445801C2 true DE2445801C2 (de) | 1985-05-09 |
Family
ID=14463599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2445801A Expired DE2445801C2 (de) | 1973-09-26 | 1974-09-25 | Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose |
Country Status (5)
Country | Link |
---|---|
US (1) | US3929995A (fr) |
JP (1) | JPS5058213A (fr) |
DE (1) | DE2445801C2 (fr) |
FR (1) | FR2244487B1 (fr) |
GB (1) | GB1474424A (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1143611B (it) * | 1977-11-03 | 1986-10-22 | Sigma Tau Ind Farmaceuti | Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche |
IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
IT1206954B (it) * | 1979-02-12 | 1989-05-17 | Sigma Tau Ind Farmaceuti | Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche |
IT1116037B (it) * | 1979-04-23 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico |
IT1133010B (it) * | 1980-05-15 | 1986-07-09 | Sigma Tau Ind Farmaceuti | Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo |
US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
US4731360A (en) * | 1985-08-16 | 1988-03-15 | Merck & Co., Inc. | Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments |
IT1231944B (it) * | 1989-05-05 | 1992-01-16 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina |
US10799564B1 (en) | 2019-05-06 | 2020-10-13 | Baxter International Inc. | Insulin premix formulation and product, methods of preparing same, and methods of using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3624887A (en) * | 1970-03-02 | 1971-12-07 | Bunker Ramo | Pin and socket removal tool |
-
1973
- 1973-09-26 JP JP48107613A patent/JPS5058213A/ja active Pending
-
1974
- 1974-07-30 GB GB3366774A patent/GB1474424A/en not_active Expired
- 1974-09-25 DE DE2445801A patent/DE2445801C2/de not_active Expired
- 1974-09-26 FR FR7432479A patent/FR2244487B1/fr not_active Expired
- 1974-09-26 US US509604A patent/US3929995A/en not_active Expired - Lifetime
Non-Patent Citations (2)
Title |
---|
Biochemistry 58, 1967, S. 796-797 * |
Physiologische Chemie, Berlin 1954, Bd. 2, T. 1a, S. 769 * |
Also Published As
Publication number | Publication date |
---|---|
FR2244487B1 (fr) | 1978-06-30 |
AU7226574A (en) | 1975-05-01 |
GB1474424A (en) | 1977-05-25 |
JPS5058213A (fr) | 1975-05-21 |
FR2244487A1 (fr) | 1975-04-18 |
US3929995A (en) | 1975-12-30 |
DE2445801A1 (de) | 1975-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69930243T2 (de) | Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu | |
DE2445801C2 (de) | Parenteral oder oral verabreichbares Arzneimittel zur Behandlung von diabetischer Ketoacidose | |
DE3137125C2 (fr) | ||
EP1782824B1 (fr) | Compositions pharmaceutiques sous forme d'hydrogel contenant de la diamino-oxydase | |
DE68915269T2 (de) | Polyvalentes entzündungshemmendes mittel. | |
DE69829290T2 (de) | Verwendung von alkanoylcarnitinderivaten zur behandlung von hyperaktivität mit aufmerksamkeitsstörungen | |
DE2716402A1 (de) | 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel | |
DE2530862C2 (de) | Verwendung von Uridin-5'-diphosphat zur Verhütung und Behandlung von Alkoholismus | |
DE2726392A1 (de) | Mittel zur bekaempfung der venoesen thrombose | |
DE69003670T2 (de) | Nicht einspritzbares karzinostatisches mittel zur vorbeugung der entzündung durch 5-fluoruracil und verfahren zur behandlung von krebs. | |
DE60203844T2 (de) | Verwendung von Hydantoin und seinen Derivaten gegen Hypalbuminämie | |
DE3875107T2 (de) | Verwendung von fructose-1,6-diphosphat zur behandlung von akuten alkoholvergiftungen und chronischem alkoholismus und verwandte pharmazeutische zusammensetzungen. | |
DE2416216C2 (de) | Oral verabreichbares pharmazeutisches Gemisch | |
CA2055661A1 (fr) | Traitement des maux d'estomac associes aux brulures d'estomac ou a une hyperacidite gastrique au moyen d'une formulationeffervescente bloquant h2 | |
DE1900772C3 (de) | Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel | |
DE3141970C2 (fr) | ||
Motew et al. | Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats | |
JPH07506568A (ja) | 糖尿病治療のための既存の薬剤の使用 | |
DE2157201C3 (de) | Verbesserte feste orale Applikationsform von Raubasin | |
DE2728589A1 (de) | Verwendung von 2-(2,2-disubstituierten)-aethylimidazolinen bei der bekaempfung von diabetes | |
DE1809119B2 (de) | Infarktprophylaktikum | |
DE2049115C3 (de) | Verwendung von Calcium-5-butylpicolinat und/oder Calcium-5-pentylpicolinat bei der Bekämpfung des Parkinsonismus mit 3-(3,4-Dihydroxyphenyl)-L-alanin (L-Dopa) | |
DE3419425A1 (de) | Verwendung von d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5h)-on als arzneimittel zur bekaempfung der hypolipidaemie | |
DE2615694A1 (de) | Pharmazeutische zusammensetzungen | |
DE69630561T2 (de) | Verwendung von 4-Amino-6-hydroxypyrazolo[3,4-d]pyrimidin zur Herstellung eines blutdrucksenkenden Mittels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |